南亚与撒哈拉以南非洲孕产妇直接发病与妊娠相关死亡、死产及新生儿死亡风险:8国基于人群的前瞻性队列研究
该研究在8个国家的9个研究点开展基于人群的前瞻性队列研究,纳入114050例妊娠,发现32.7%的妊娠至少发生一种主要直接孕产妇疾病,南亚负担约为撒哈拉以南非洲的两倍。直接孕产妇疾病与妊娠相关死亡、死产及新生儿死亡均相关,提示需加强识别与治疗。
要点
- 约三分之一妊娠发生至少一种主要直接孕产妇疾病,南亚负担高于撒哈拉以南非洲。
- 直接孕产妇疾病与妊娠相关死亡、死产及新生儿死亡均相关。
- 需强化南亚和撒哈拉以南非洲地区孕产妇疾病的识别与治疗。
核心结论
- 南亚和撒哈拉以南非洲地区约三分之一妊娠发生至少一种主要直接孕产妇疾病。
- 直接孕产妇疾病与妊娠相关死亡、死产及新生儿死亡均相关。
- 该地区卫生规划需加强识别和治疗孕产妇疾病以预防不良结局。
研究设计与样本
- 前瞻性队列研究,2012至2015年在南亚和撒哈拉以南非洲8个国家的9个研究点开展。
- 对15至49岁育龄女性进行基于人群的监测以识别妊娠,随访至分娩及产后42天。
- 纳入妊娠满28周或孕期死亡的孕妇,最终分析114050例妊娠。
主要发现
- 32.7%的纳入妊娠至少发生一种主要直接孕产妇疾病。
- 南亚负担为43.9%(95%CI 27.8%至60.0%),撒哈拉以南非洲为23.7%(95%CI 19.8%至27.6%)。
- 产前出血报告于2.2%(95%CI 1.5%至2.9%)妊娠,严重产后出血报告于1.7%(95%CI 1.2%至2.2%)妊娠。
- 子痫前期或子痫报告于1.4%(95%CI 0.9%至2.0%)妊娠,单纯妊娠期高血压报告于7.4%(95%CI 4.6%至10.1%)妊娠。
- 每10万次分娩有187例妊娠相关死亡,每1000次分娩有27例死产,每1000例活产有28例新生儿死亡。
关键数值与推荐
- 子痫前期或子痫报告于1.4%(95%CI 0.9%至2.0%)妊娠。
- 妊娠期高血压报告于7.4%(95%CI 4.6%至10.1%)妊娠。
- 产程延长或梗阻报告于约11.1%(95%CI 5.4%至16.8%)妊娠。
- 晚孕期产前感染临床特征见于9.1%(95%CI 5.6%至12.6%)妊娠,产后感染见于8.6%(95%CI 4.4%至12.8%)妊娠。
- 妊娠相关死亡率为每10万次分娩187例,死产率为每1000次分娩27例,新生儿死亡率为每1000例活产28例。
临床怎么用
- 在资源有限地区应加强孕期和产后对主要直接孕产妇疾病的识别与治疗。
- 关注南亚地区较高的孕产妇疾病负担,针对性强化卫生规划。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal morbidity occurs several times more frequently than mortality, yet data on morbidity burden and its effect on maternal, foetal, and newborn outcomes are limited in low- and middle-income countries. We aimed to generate prospective, reliable population-based data on the burden of major direct maternal morbidities in the antenatal, intrapartum, and postnatal periods and its association with maternal, foetal, and neonatal death in South Asia and sub-Saharan Africa. METHODS AND FINDINGS: This is a prospective cohort study, conducted in 9 research sites in 8 countries of South Asia and sub-Saharan Africa. We conducted population-based surveillance of women of reproductive age (15 to 49 years) to identify pregnancies. Pregnant women who gave consent were include in the study and followed up to birth and 42 days postpartum from 2012 to 2015. We used standard operating procedures, data collection tools, and training to harmonise study implementation across sites. Three home visits during pregnancy and 2 home visits after birth were conducted to collect maternal morbidity information and maternal, foetal, and newborn outcomes. We measured blood pressure and proteinuria to define hypertensive disorders of pregnancy and woman's self-report to identify obstetric haemorrhage, pregnancy-related infection, and prolonged or obstructed labour. Enrolled women whose pregnancy lasted at least 28 weeks or those who died during pregnancy were included in the analysis. We used meta-analysis to combine site-specific estimates of burden, and regression analysis combining all data from all sites to examine associations between the maternal morbidities and adverse outcomes. Among approximately 735,000 women of reproductive age in the study population, and 133,238 pregnancies during the study period, only 1.6% refused consent. Of these, 114,927 pregnancies had morbidity data collected at least once in both antenatal and in postnatal period, and 114,050 of them were included in the analysis. Overall, 32.7% of included pregnancies had at least one major direct maternal morbidity; South Asia had almost double the burden compared to sub-Saharan Africa (43.9%, 95% CI 27.8% to 60.0% in South Asia; 23.7%, 95% CI 19.8% to 27.6% in sub-Saharan Africa). Antepartum haemorrhage was reported in 2.2% (95% CI 1.5% to 2.9%) pregnancies and severe postpartum in 1.7% (95% CI 1.2% to 2.2%) pregnancies. Preeclampsia or eclampsia was reported in 1.4% (95% CI 0.9% to 2.0%) pregnancies, and gestational hypertension alone was reported in 7.4% (95% CI 4.6% to 10.1%) pregnancies. Prolonged or obstructed labour was reported in about 11.1% (95% CI 5.4% to 16.8%) pregnancies. Clinical features of late third trimester antepartum infection were present in 9.1% (95% CI 5.6% to 12.6%) pregnancies and those of postpartum infection in 8.6% (95% CI 4.4% to 12.8%) pregnancies. There were 187 pregnancy-related deaths per 100,000 births, 27 stillbirths per 1,000 births, and 28 neonatal deaths per 1,000 live births with variation by country and region. Direct maternal morbidities were associated with each of these outcomes. CONCLUSIONS: Our findings imply that health programmes in sub-Saharan Africa and South Asia must intensify their efforts to identify and treat maternal morbidities, which affected about one-third of all pregnancies and to prevent associated maternal and neonatal deaths and stillbirths. TRIAL REGISTRATION: The study is not a clinical trial.
引用
- Aftab F, Ahmed I, Ahmed S, et al. Direct maternal morbidity and the risk of pregnancy-related deaths, stillbirths, and neonatal deaths in South Asia and sub-Saharan Africa: A population-based prospective cohort study in 8 countries. PLoS Med. 2021. PMID: 34181649. doi:10.1371/journal.pmed.1003644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。